Keratinocyte carcinoma (KC) is the most common type of cancer among white populations,
but it is even more common among solid organ transplant recipients (OTRs). The most …

The number of solid organ transplants has been increasing annually worldwide. Advances
in transplantation surgery and community awareness of organ donation have been key …

This review outlines our current understanding of the relationship between
immunosuppression and skin cancer. Primary immunodeficiencies increase the incidence of …

Background: Nonmelanoma skin cancer (NMSC) in renal transplant recipients is common
and associated with significant morbidity and mortality. The aim of the present systematic …

With an increasing number of renal transplant recipients (RTRs) and improving patient
survival, a higher incidence of non‐melanoma skin cancer (NMSC) has been observed …

Skin cancer is the most common malignancy worldwide, with increasing incidence seen in
many countries, including the United States. In 2013, it is estimated that there will be 3.5 …

Background Solid organ transplant recipients (SOTR) are at high risk of keratinocyte
carcinoma (KC). Long‐term evidence for acitretin as chemoprophylaxis in this population is …

Background Kidney transplant recipients are at increased risk of keratinocyte cancers,
namely squamous cell and basal cell carcinomas (SCCs and BCCs). This is primarily due to …

Herein, we characterized the percentage of tacrolimus to the combined sirolimus and
tacrolimus trough levels (tacrolimus%) observed during islet transplant-associated immune …

Background Immunosuppression is a known risk factor for the development of cutaneous
squamous cell carcinoma (CSCC), especially in solid organ transplant recipients and …